New developments in renal transplant pathology

Current Diagnostic Pathology

Volumn 6, Issue 4, 2000, Pages 219-228

  Roberts, I S D ^a   Solez, K ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Banff classification; Kidney; Rejection; Renal fibrosis; Transplant

Indexed keywords

CLINICAL PROTOCOL; CONFERENCE PAPER; CYTOMEGALOVIRUS; DISEASE CLASSIFICATION; EPSTEIN BARR VIRUS; GLOMERULITIS; GRAFT FAILURE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PATHOLOGY; POLYOMA VIRUS;

EID: 0034524299     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2000.0040     Document Type: Conference Paper

References (52)

1. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
2. The Banff 97 working classification of renal allograft pathology
3. Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation
4. Banff criteria as predictors of outcome following acute renal allograft rejection
5. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome
6. Correlation between Banff classification, acute renal rejection scores and reversal of rejection
7. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection
8. The prognostic significance of specific arterial lesions in acute renal allograft rejection
9. Significance of the Banff Borderline Biopsy
10. Clinical significance of renal allograft biopsies with 'borderline changes' as defined in the Banff schema
11. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies
12. Early protocol renal allograft biopsies and graft outcome
13. Sequential protocol biopsies in renal transplant patients
14. Pathologic features of acute renal allograft rejection associated with donor-specific antibody
15. The significance of monocytes in glomeruli of human renal transplants
16. Endocapillary glomerulitis in the renal allograft
17. Eosinophils in acute renal allograft rejection
18. Diagnosis of early acute renal allograft rejection by evaluation of multiple histological features using a Bayesian belief network
19. A neural network approach to the biopsy diagnosis of early acute renal transplant rejection
20. Clinical Validation and reproducibility of the Banff schema for renal allograft pathology
21. Reproducibility of the Banff classification of renal allograft pathology. Inter- and intra-observer variation
22. A UK-wide trial of the Banff classification of renal transplant pathology in routine diagnostic practice
23. Clinical response and temporal patterns of acute cellular rejection: Relationship to chronic transplant nephropathy
24. Clinical correlates to chronic renal allograft rejection
25. Molecular mechanisms of chronic renal allograft rejection
26. Marchand Set al Post-transplantation polyomavirus infections
27. Human polyoma virus-associated interstitial nephritis in the allograft kidney
28. Human polyoma virus in renal allograft biopsies: Morphological findings and correlations with urine cytology
29. Incidence and consequences of post-transplantation lymphoproliferative disorders
30. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders
31. Histopathology of renal post-transplant lymphoproliferation: Comparison with rejection using the Banff schema
32. Demonstration by light microscopy of cytomegalovirus on a renal biopsy of a renal allograft recipient: Confirmation by immunohistochemistry and in situ hybridization
33. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus
34. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients
35. CMV infection, class II antigen expression and human kidney allograft rejection
36. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients
37. Histopathological findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine
38. Beneficial effects of treatment of early subclinical rejection: A randomized study
39. Histological outcome of acute cellular rejection in kidney transplantation after treatment with methylprednisolone
40. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection
41. Computerized histomorphometric assessment of protocol renal transplant biopsy specimens for surrogate markers of chronic rejection
42. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries
43. An analysis of monocyte/macrophage subsets and granulocyte-macrophage colonystimulating factor expression in renal allograft biopsies
44. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages
45. Histologic and immunophenotypic evaluation of pretreatment renal biopsies in, OKT3-treated allograft rejections
46. Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection
47. Thrombosponcin and the Expression of Adhesion Molecules in Acute and Chronic: Renal Transplant Rejection
48. Urinary and serum type III collagen: Markers of renal fibrosis
49. Is persistent TGFβI expression the mechanism responsible for chronic renal allograft loss?
50. Transforming growth factor beta I in renal allograft recipients
51. Association of TGFβ-I gene polymorphisms with in vivo plasma TGFβ-I expression and chronic vascular rejection in renal transplant recipients